Note that the Masimo trade secret lawsuit against Apple is separate from both an ITC injunction preventing the sale of Apple ...

As always, the man from Masimo has strong words. Apple has replied. The firm claims that the blood oxygen sensor is accurate, and that, in essence, Kiani isn’t telling the truth. The difference ...

Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

User-friendly touch-screen patient monitor measures ECG, SpO 2, NIBP, heart rate, temperature and respiration. Offers optional dual IBP, and EtCo 2 — Now with Masimo SET ® Pulse Oximetry!

Smartwatches gather vast amounts of data about our physiology. Now their technology is being harnessed like never before.

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Kiani has been in it since starting Masimo in 1989. Along with being chairman and CEO, he holds more than 500 patents or ...

Vanderbilt University Medical Center is launching Masimo Radius VSM™ advanced wireless patient-worn vital signs monitoring ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...

Wells Fargo analyst Vik Chopra has assigned their bullish stance on MASI stock, giving a Buy rating yesterday. Vik Chopra has given his Buy ...